Eledon宣佈完成了第2期Bestow臨床試驗的招募，評估Tegoprubart用於預防

快訊 · 09/04 19:00

Eledon Announces Completion of Enrollment in Phase 2 Bestow Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients

Eledon宣佈完成了第2期Bestow臨床試驗的招募，評估Tegoprubart用於預防腎移植患者器官排斥。